We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+471.57%
AUM
$891M
AUM Growth
-$24.5M
Cap. Flow
-$27M
Cap. Flow %
-3.03%
Top 10 Hldgs %
26.36%
Holding
379
New
18
Increased
130
Reduced
137
Closed
20

Top Sells

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$4.99M
2
ENVA icon
Enova International
ENVA
+$3.95M
3
NVMI
Nova
NVMI
+$2.95M
4
AAPL icon
Apple
AAPL
+$2.35M
5
AJG icon
Arthur J. Gallagher & Co
AJG
+$2.18M

Sector Composition

Rank Sector Weight
1 Technology 18.14%
2 Financials 12.01%
3 Consumer Discretionary 7.88%
4 Healthcare 6.79%
5 Industrials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIGA icon
301
SIGA Technologies
SIGA
$205M
$286K 0.03%
53,546
IBTK icon
302
iShares iBonds Dec 2030 Term Treasury ETF
IBTK
$1B
$283K 0.03%
14,350
CCS icon
303
Century Communities
CCS
$2B
$274K 0.03%
4,769
ZYME icon
304
Zymeworks
ZYME
$1.75B
$274K 0.03%
10,925
ICVT icon
305
iShares Convertible Bond ETF
ICVT
$7.58B
$267K 0.03%
2,624
CTRE icon
306
CareTrust REIT
CTRE
$9.26B
$265K 0.03%
7,218
+9
+0.1% +$346
NWPX icon
307
NWPX Infrastructure Inc
NWPX
$1.1B
$264K 0.03%
3,394
AORT icon
308
Artivion
AORT
$1.38B
$255K 0.03%
6,972
TSCO icon
309
Tractor Supply
TSCO
$18.6B
$253K 0.03%
5,577
-18,541
-77% -$945K
IBTG icon
310
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
$2.22B
$252K 0.03%
11,000
IWY icon
311
iShares Russell Top 200 Growth ETF
IWY
$16.6B
$248K 0.03%
997
-80
-7% -$21.2K
TLH icon
312
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
$247K 0.03%
2,453
LMAT icon
313
LeMaitre Vascular
LMAT
$1.84B
$243K 0.03%
+2,222
New +$212K
TBPH icon
314
Theravance Biopharma
TBPH
$880M
$241K 0.03%
14,833
ISTR icon
315
Investar Holding Corp
ISTR
$419M
$240K 0.03%
8,819
USIG icon
316
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$240K 0.03%
4,690
RSPD icon
317
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$333M
$238K 0.03%
4,454
UFPT icon
318
UFP Technologies
UFPT
$2.46B
$238K 0.03%
1,230
IRMD icon
319
iRadimed
IRMD
$1.13B
$236K 0.03%
2,454
COLL icon
320
Collegium Pharmaceutical
COLL
$846M
$235K 0.03%
7,110
+1,170
+20% +$49.5K
IOSP icon
321
Innospec
IOSP
$2.3B
$220K 0.02%
3,015
-6,934
-70% -$540K
BLBD icon
322
Blue Bird Corp
BLBD
$2.04B
$217K 0.02%
+3,819
New +$206K
ACU icon
323
Acme United Corp
ACU
$224M
$217K 0.02%
+4,824
New +$210K
PFE icon
324
Pfizer
PFE
$150B
$214K 0.02%
+7,631
New +$203K
RCKY icon
325
Rocky Brands
RCKY
$351M
$211K 0.02%
+5,445
New +$198K

Similar funds

James Investment Research's Q1 2026 Portfolio in Review

As of Q1 2026, James Investment Research held 379 positions worth $891M, down 2.7% from $916M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

James Investment Research withdrew a net $27M in Q1 2026, closing 20 positions and reducing 137 holdings. Its most notable exit was Dynavax Technologies, an estimated $1.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, James Investment Research opened a new position in Western Digital worth $1.75M.

  • James Investment Research's largest Q1 2026 buy was Western Digital: 6,476 shares worth $1.75M.
  • James Investment Research added most to Installed Building Products in Q1 2026, an estimated $1.42M increase.
  • James Investment Research's biggest Q1 2026 reduction was iShares Gold Trust, cutting an estimated $4.99M.
  • James Investment Research fully exited Dynavax Technologies in Q1 2026, selling an estimated $1.28M.
  • James Investment Research's ten largest holdings make up 26% of its $891M portfolio in Q1 2026.
  • James Investment Research opened 18 new positions and closed 20 in Q1 2026.
  • James Investment Research's portfolio value fell 2.7% quarter-over-quarter to $891M.

Based on James Investment Research's 13F filing for Q1 2026, filed 24 Apr 2026.